Multivariate discrimination for phenylketonuria (PKU) and non-PKU hyperphenylalaninemia after analysis of newborns' dried blood-spot specimens for six amino acids by ion-exchange chromatography

Clinical Chemistry

Volumn 44, Issue 2, 1998, Pages 317-326

  Reilly, Andrew A ^a,b   Bellisario, Ronald ^a   Pass, Kenneth A ^a,b  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY AT ALBANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD ANALYSIS; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERPHENYLALANINEMIA; ION EXCHANGE CHROMATOGRAPHY; MAPLE SYRUP URINE DISEASE; MULTIVARIATE ANALYSIS; NEWBORN; NEWBORN SCREENING; PHENYLKETONURIA; QUALITY CONTROL; QUANTITATIVE DIAGNOSIS;

ACER; BACTERIA (MICROORGANISMS); BIA;

EID: 0031887596     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.2.317     Document Type: Article

References (36)

1. Walker V, Clayton BE, Ersser RS, Francis DEM, Lilly P, Senkins JWT, et al. Hyperphenylalaninaemia of various types among three-quarters of a million neonates tested in a screening programme. Arch Dis Child 1981;56:759-64.
2. Zschocke J, Carson DJ. Transient neonatal hyperphenylalaninaemia is not related to mutations at the phenylalanine hydroxylase gene. J Inher Metab Dis 1995;18:369-70.
3. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, Vol. 1, 7th ed. New York: McGraw-Hill, 1995:1015-75.
4. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Lindsay F, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 1993;39:66-71.
5. Ulrey JR, Nahata MC. Drug interferences with amino acid analysis. J Pharm Tech 1990;6:64-73.
6. Chace DH, Hillman SL, Millington DS, Kahler SG, Adam BW, Levy HL. Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry. Clin Chem 1996;42:349-55.
7. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in: large populations of newborn infants. Pediatrics 1963;32:338-43.
8. Hoffman GL, Laessig RH, Hassemer DJ, Makowski ER. Dual-channel, continuous-flow system for determination of phenylalanine and galactose: application to newborn screening. Clin Chem 1984;30:287-90.
9. Gerasimova NS, Steklova IV, Tuuminen T. Fluorometric method for phenylalanine microplate assay adapted for phenylketonuria screening. Clin Chem 1989;35:2112-5.
10. Elvers LH, Diependaal GAM, Blonk HJ, Loeber JG. Phenylketonuria screening using the Quantase phenylalanine kit in combination with a microfilter system and the dye tartrazine. Screening 1995; 3:209-23.
11. Roesel AR, Blankenship PR, Hommes F. HPLC assay of phenylalanine and tyrosine in blood spots on filter-paper. Clin Chim Acta 1986;156:91-6.
12. Rudy JL, Rutledge JC, Lewis SL. Phenylalanine and tyrosine in serum and eluates from dried blood spots as determined by reversed-phase liquid chromatography. Clin Chem 1987;33: 1152-4.
13. Vollmer DW, Jinks DC, Guthrie R. Isocratic reverse-phase liquid chromatography assay for amino acid metabolic disorders using eluates of dried blood spots. Anal Biochem 1990;189:115-21.
14. Qu Y, Miller JB, Slocum RH, Shapira E. Rapid automated quantitation of isoleucine, leucine, tyrosine, and phenylalanine from dried blood filter paper specimens. Clin Chim Acta 1991;203: 191-8.
15. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.
16. Gnanadesikan R, Blashfield RK, Brieman L, Dunn OJ, Friedman JH, Fu K-S, et al. Discriminant analysis and clustering. Stat Sci 1989;4:34-69.
17. Hastie T, Tibshirani R, Buja A. Flexible discriminant analysis by optimal scoring. J Am Stat Assoc 1994;89:1255-70.
18. Hannon WH, Aziz KJ, Collier FC, Fisher DA. Blood collection on filter paper for neonatal screening programs, 2nd ed. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992; 12:1-23.
19. Levy HL, Simmons JR, MacCready RA. Stability of amino acids and galactose in the newborn screening filter paper specimen. J Pediatr 1985;107:757-60.
20. Lundsjö A, Hagelberg S, Palmér K, Linblad BS. Amino acid profiles by HPLC after filter paper sampling: 'appropriate technology' for monitoring of nutritional status. Clin Chim Acta 1990;191:201-10.
21. Madira WM, Xavier F, Stern J, Wilcox A, Barron JL. Determination and assessment of the stability of phenylalanine and tyrosine in blood spots by HPLC [Letter]. Clin Chem 1992;38:2162-3.
22. Mabry CH, Reid MC, Kuhn RJ. A source of error in phenylketonuria screening. Am J Clin Pathol 1988;90:279-83.
23. Hubbard R, Slocum R. Drug interference in amino acid analysis: a graphic presentation of pediatric antibiotics [Abstract]. Clin Chem 1994;40:1093.
24. DiCiccio TJ, Romano JP. A review of bootstrap confidence intervals. J R Stat Soc Ser B 1988;50:338-54.
25. Paulson AS, Delehanty TA. Sensitivity analysis in experimental design. In: Hiener KW, Sacher RS, Wilkinson JW, eds. Computer science and statistics: proceedings of the 14th symposium on the interface. New York: Springer-Verlag, 1982:52-7.
26. Shapira E, Blitzer MG, Miller JB, Africk DK. Biochemical genetics. A laboratory manual. New York: Oxford University Press, 1989: 89-100.
27. Chace DH, Millington DS, Hillman SL. Further progress in the automation of tandem mass spectrometry used to analyze amino acids and acylcarnitines from neonatal blood spots. In: Glass M, ed. Proceedings of 10th neonatal screening symposium. Seattle, WA: Washington State Public Labs., 1994:24-7.
28. Levy HL, Waisbren SE, Lobbregt D, Allred E, Leviton A, Koch R, et al. Maternal non-phenylketonuric mild hyperphenylalaninemia. Eur J Pediatr 1996;155(Suppl 1):S20-5.
29. Weglage J, Ullrich K, Pietsch M, Fünders B, Zass R, Koch HG. Untreated non-phenylketonuric hyperphenylalaninemia: intellectual and neurological outcome. Eur J Pediatr 1996;155(Suppl 1):S26-8.
30. Costello PM, Beasley MG, Tillotson SL, Smith I. Intelligence in mild atypical phenylketonuria. Eur J Pediatr 1994;153:260-3.
31. Committee on Genetics, American Academy of Pediatrics. Newborn screening fact sheets. Pediatrics 1996;98:473-501.
32. Berlin CM, Levy HL, Hanley WB. Delayed increase in blood phenylalanine concentration in phenylketonuric children initially classified as mild hyperphenylalaninemia. Screening 1995;4: 35-9.
33. Okano Y, Eisensmith RC, Güttler F, Lichter-Konecki U, Konecki D, Trefz FK, et al. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 1991;324:1232-8.
34. Schoonheyt WE, Clarke JTR, Hanley WB, Johnson JM, Lehotay DC. Feto-maternal plasma phenylalanine concentration gradient from 19 weeks gestation to term. Clin Chim Acta 1994;225:165-9.
35. Koch R, Levy H, Hanley W, Matalon R, Rouse B, Trefz F, de la Cruz F. Outcome implications of the International Maternal Phenylketonuria Collaborative Study (MPKUCS): 1994. Eur J Pediatr 1996; 155(Suppl 1):S162-4.
36. Koch R, Friedman EG, Azen C. Reproductive outcome of pregnant women with hyperphenylalaninemia. Metabol Currents 1996;8: 1-4. (Ross Products Div., Abbott Labs., 625 Cleveland Ave., Columbus, OH 43215).